Capricor Therapeutics
CAPR
#7990
Rank
โ‚ฌ0.24 B
Marketcap
5,44ย โ‚ฌ
Share price
-4.36%
Change (1 day)
-61.47%
Change (1 year)

Capricor Therapeutics (CAPR) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ84.3 Million

According to Capricor Therapeutics 's latest financial reports the company has โ‚ฌ84.3 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Capricor Therapeutics - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.14 B307.61%
2023-12-31โ‚ฌ35.72 M-7.5%
2022-12-31โ‚ฌ38.61 M25.36%
2021-12-31โ‚ฌ30.8 M15.99%
2020-12-31โ‚ฌ26.55 M200.96%
2019-12-31โ‚ฌ8.82 M39.12%
2018-12-31โ‚ฌ6.34 M-46.12%
2017-12-31โ‚ฌ11.77 M-23.54%
2016-12-31โ‚ฌ15.39 M24.08%
2015-12-31โ‚ฌ12.4 M87.82%
2014-12-31โ‚ฌ6.6 M343.74%
2013-12-31โ‚ฌ1.48 M-54.86%
2012-12-31โ‚ฌ3.29 M312.18%
2011-12-31โ‚ฌ0.8 M-68.49%
2010-12-31โ‚ฌ2.53 M14.58%
2009-12-31โ‚ฌ2.21 M-43.67%
2008-12-31โ‚ฌ3.93 M-64.61%
2007-12-31โ‚ฌ11.11 M
2005-12-31โ‚ฌ0 M-49.33%
2004-12-31โ‚ฌ0 M-45.38%
2003-12-31โ‚ฌ0 M3483.58%
2002-12-31โ‚ฌ0 M-86.46%
2001-12-31โ‚ฌ0 M-98.74%
2000-12-31โ‚ฌ0.01 M
1999-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Cytokinetics
CYTK
โ‚ฌ0.82 B 876.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ2.15 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ15.87 B 18,732.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.95 B 1,031.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ0.49 B 491.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ2.6 M-96.91%๐Ÿ‡บ๐Ÿ‡ธ USA